期刊文献+

促红细胞生成素对糖尿病大鼠心肌纤维化及心功能的影响 被引量:1

Effects of erythropoietin on myocardial interstitial fibrosis and cardiac function in diabetic rats
原文传递
导出
摘要 目的探讨促红细胞生成素(EPO)对糖尿病大鼠心肌纤维化及心功能的影响。方法采用链脲佐菌素一次性腹腔注射成功建立糖尿病动物模型雄性SD大鼠20只,随机均分为模型对照(A)组和EPO处理(B)组;另取10只SD大鼠作为空白对照(C)组。12周后,称取心脏重量和大鼠体重,计算心体比;Western blot检测心肌组织转化生长因子β(TGF-β)表达;天狼猩红染色测心肌组织胶原含量;心脏超声检测心功能。结果与C组比较,A组心肌组织TGF-β蛋白表达和胶原含量明显增加(P<0.01),心体比、左室舒张末期内径(LVDd)和左室收缩末期内径(LVDs)明显增加(P<0.05),射血分数(EF)明显下降(P<0.01)。与A组比较,B组心肌组织TGF-β蛋白表达及胶原含量均明显减少(P<0.01),EF值增加(P<0.05),LVD d和LVDs明显减少(P<0.05)。结论EPO通过减少糖尿病大鼠TGF-β的表达来逆转心肌间质纤维化,改善心功能。 Objective To investigate the effects of erythropoietin on myocardial interstitial fibrosis and cardiac function in diabetic rats.Methods After successfully established the STZ-induced rat diabetic models,20 male SD rats were equally randomized into two groups of A(model control) and B(treated with EPO).Another 10 SD rats were taken as blank control(group C).Twelve weeks later,echocardiography was conducted for evaluating cardiac function.The ratio of heart weight to body weight was calculated.The expression of transforming growth factor-β(TGF-β) in myocardium was detected by Western blot.Myocardial collagen content was measured by Picrosirius Red staining.Results Compared to group C,the expression of TGF-β in myocardium and myocardial collagen content were increased(P0.01),the ratio of heart weight to body weight and systolic-and diastolic internal diameters were all increased,but ejection fraction of the left ventricule was reduced(P0.05).Compared to group A,the expression of TGF-β in myocardium and myocardial collagen content were significantly lower and cardiac function was much better in group B(P0.05).Conclusion EPO may reduce cardiac interstitial fibrosis and improve cardiac function in diabetic rats by decreasing TGF-β expression in myocardium.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第23期2796-2798,共3页 Jiangsu Medical Journal
关键词 糖尿病 促红细胞生成素 心肌纤维化 转化生长因子Β Diabetes mellitus Erythropoietin Myocardial interstitial fibrosis Transforming growth factor beta
  • 相关文献

参考文献1

二级参考文献16

  • 1Wild SH & Forouhi NG, What is the scale of the future diabetes epidemic, and how certain are we about it? Diabetologia. 2007, 50(5) : 903-905.
  • 2Herpel E, Pritsch M, Koch A, Dengler TJ, Schirreacher P & Sehnabel PA, Interstitial fibrosis in the heart: differences in extracellular matrix proteins and matrix metalloproteinases in end-stage dilated, ischaemic and valvular cardiomyopathy. Histopathology. 2006, 48 (6) : 736-747.
  • 3Bujak M & Frangogiannis NG, The role of TGF-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc. Res. 2007, 74(2): 184-195.
  • 4Leask A & Abraham DJ, TGF-beta signaling and the fibrotic response. Faseb. J. 2004, 18(7): 816-827.
  • 5Mimura Y, Ihn H, Jinnin M, Asano Y, Yamaue K & Tamaki K, Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts. Am. J. Pathol. 2005, 166 (5) : 1 451-1 463.
  • 6Zhang XM, Shen F, Xv ZY, Yah ZY & Han S, Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of STZ-induced rats. Int. J. Cardiol.2005, 105(2): 192-197.
  • 7Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J & Entman ML, Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation. 2005, 111(22): 2935- 2 942.
  • 8Chatila K, Ren G, Xia Y, Huebener P, Bujak M & Frangogiannis NG, The role of the thrombospondins in healing myocardial infarcts. Cardiovasc. Hematol. Agents. Med. Chem. 2007, 5(1): 21-27.
  • 9Bhattachatyya S, Marinic TE, Krukovets 1, Hoppe G & Stenina OI, Cell type-specific post-transcriptional regulation of production of the potent antiangiogenic and proatherogenic protein thrombospondin-1 by high glucose. J. Biol. Chem. 2008, 283(9) : 5 699-5 707.
  • 10Zhou J, Wang L, Ling S & Zhang X, Expression changes of growth-associated protein-43 (GAP-43) and mitogen-activated protein kinase phosphatase-1 (MKP-1) and in hippocampus of streptozotocin-indueed diabetic cognitive impairment rats. Exp. Neurol. 2007, 206(2): 201-208.

共引文献1

同被引文献8

  • 1Joannes-Boyau O, Honore PM, Boer W, et al. Septic acute kidney injury and tubular apoptosis: never a Lone Ranger[-J]. Intensive Care Med, 2010,36 (3) : 385-388.
  • 2Sugiura H,Yoshida T9 Mitobe M, et al. Klotho reduces apop- tosis in experimental ischaemic acute kidney injury via HSP-70EJ]. Nephrol Dial Transplant, 2010,25 (1) : 60-68.
  • 3Ates E,Yalcin AU,Yilmaz S,et al. Protective effect of eryth- ropoietin on renal ischemia and reperfusion injuryJ]. ANZ J Surg, 2005,75(12) .. 1100-1105.
  • 4Kiris I, Kapan S, Kilbas A, et al. The protective effect of erythropoietin on renal injury induced by abdominal aortic- ischemia-reperfusion in rats[J]. J Surg Res, 2008,149 (2) : 206- 213.
  • 5Yang CW, Li C, Jung JY, et al. Preconditioning with erythro- poietin protects against subsequent ischemia-reperfusion injury in rat kidney[-J]. FASEB J,2003,17(12) 1754-1755.
  • 6Endre ZH, Walker R J, Piekering JW, et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)l-J]. Kidney Int,2010,77(11) : 1020-1030.
  • 7徐艺,何永成,栾韶东,马彬,刘洪萍.促红细胞生成素在急性肾功能衰竭患者中的临床应用观察[J].中国医药导报,2009,6(14):19-21. 被引量:2
  • 8陈启,蒋维维,王亮,孔连宝.重组人促红细胞生成素对大鼠肝脏缺血-再灌注损伤的保护作用[J].江苏医药,2012,38(1):1-3. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部